Seller record · Telehealth service

Arbor

By Paul Harris, Standards EditorRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 3 of 8 criteria. S3, pharmacy identification: The pages say medication is compounded by licensed 503A and 503B U.S. pharmacies in a partner network, and no pharmacy is named in the footer, the answers, the terms or the privacy policy. 2 more criteria also fail; see the table below.

At a glance

ArborTelehealth service

5/8criteria passed

Price: Semaglutide from $89 a month, tirzepatide from $119
Sells: compounded semaglutide, compounded tirzepatide, sermorelin, and 2 more
FDA letters: None on file

Visit Arbor See all eight dispositions

Telehealth service. Passes 5 of 8 criteria. Recorded against Standard v1.1.

A telehealth weight loss program selling compounded semaglutide and tirzepatide, sermorelin, NAD+ and glutathione, with a results guarantee and dietitian support after treatment. It prints starting prices only, and two different sets of them, names no filling pharmacy, and consults through a partner medical group.

Operating entity Harbor Health Inc.

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	Arbor's semaglutide page; Arbor's website
S2	Prescription gating	PASS	Arbor's quiz page; Arbor's semaglutide page
S3	Pharmacy identification	FAIL	Arbor's semaglutide page; Arbor's FAQ; Arbor's terms
S4	Compounding disclosure	FAIL	Arbor's FAQ; Arbor's website
S5	Analytical documentation	FAIL	Arbor's website; Arbor's semaglutide page
S6	Business address	PASS	Arbor's terms; Arbor's privacy page; Arbor's payment and billing consent; Arbor's telehealth consent
S7	Price disclosure	PASS	Arbor's semaglutide page; Arbor's tirzepatide page; Arbor's quiz page; Arbor's website; Arbor's sermorelin page; Arbor's NAD+ page; Arbor's glutathione page
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSA board-certified physician reviews each health history and confirms that treatment is appropriate before anything ships, and consultations are provided through the partner medical group MD Integrations.Source: Arbor's semaglutide page; Arbor's website.

S2PASSThe start button opens an eligibility quiz whose first screen asks height and weight, and a buyer who is not a fit is not charged.Source: Arbor's quiz page; Arbor's semaglutide page.

S3FAILThe pages say medication is compounded by licensed 503A and 503B U.S. pharmacies in a partner network, and no pharmacy is named in the footer, the answers, the terms or the privacy policy.Source: Arbor's semaglutide page; Arbor's FAQ; Arbor's terms.

S4FAILThe answers page says the service provides FDA-approved GLP-1 medications and works with pharmacies to dispense FDA-approved medications, while every program on the site is compounded. The footer says compounded medications are not reviewed by the FDA, and another answer says compounded semaglutide is not FDA-approved, which does not withdraw the claim.Source: Arbor's FAQ; Arbor's website.

S5FAILThe home page says the medication is purity and potency tested, and no certificate of analysis or lot document is published.Source: Arbor's website; Arbor's semaglutide page.

S6PASSHarbor Health Inc. at 8 The Green # 25407, Dover DE 19901, printed in the terms as its principal place of business and repeated in the privacy policy, the billing consent and the telehealth consent.Source: Arbor's terms; Arbor's privacy page; Arbor's payment and billing consent; Arbor's telehealth consent.

S7PASSThe product pages and the quiz print compounded semaglutide from $89 a month and compounded tirzepatide from $119 a month, flat as the dose rises, while the home page prints semaglutide from $99 and tirzepatide from $149 a month. Sermorelin and NAD+ from $99 a month and glutathione from $89 a month, and the sermorelin and NAD+ pages say multi-month prepaid plans save up to $600 against monthly billing, with no monthly figure printed.Source: Arbor's semaglutide page; Arbor's tirzepatide page; Arbor's quiz page; Arbor's website; Arbor's sermorelin page; Arbor's NAD+ page; Arbor's glutathione page.

S8PASSNo FDA warning letter names Arbor or Harbor Health Inc., and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide, sermorelin, NAD+ injection, glutathione.

Other sellers of the same products

Who sells semaglutide Who sells tirzepatide Who sells sermorelin Who sells NAD+Who sells glutathione

Visit Arbor

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.